Peter de Bruijn

Also affiliated with Erasmus University Rotterdam

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma”.

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma

Pharmaceuticals(2021)10.3390/ph14010046

N/A

0.373DataRank · unranked

11 citations

Leni van Doorn, Sander Bins, Dave Sprengers, Peter de Bruijn, Roelof W. F. van Leeuwen +4 more

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0332

N/A

0.345DataRank · unranked

9 citations

Mike Boeckman, Yan Yang, Kevin M. Huang, Peter de Bruijn, Mahesh R. Nepal +11 more

Nanoparticle entrapped docetaxel (CPC634) enhances intratumoral docetaxel exposure compared to conventional docetaxel (Cd) in patients with solid tumors.

Journal of Clinical Oncology(2019)10.1200/jco.2019.37.15_suppl.3096

N/A

0.165DataRank · unranked

2 citations

Ruben A.G. van Eerden, Marte A.M. van Hylckama Vlieg, Esther Oomen De Hoop, Peter de Bruijn, Cristianne J.F. Rijcken +5 more